Publicaties

Didden R, VanDerNagel JEL, van Duijvenbode N, Otten R, Poelen E.A.P..  In Press.  Substance abuse. Handbook of dual diagnosis: Assessment, diagnosis and treatment in persons with intellectual disabilities.

Bruijnen CJWH, Young SY, Marx M, Seedat S.  2019.  Social anxiety disorder and childhood trauma in the context of anxiety (behavioural inhibition), impulsivity (behavioural activation) and quality of life. South African Journal of Psychiatry. 25:1-7.

van Lier HG, Pieterse ME, Garde A, Postel MG, de Haan H.A., Vollenbroek-Hutten MMR, Schraagen JMaarten, Noordzij ML.  2019.  A standardized validity assessment protocol for physiological signals from wearable technology: Methodological underpinnings and an application to the E4 biosensor. Behav Res Methods.

VanDerNagel JEL, van Duijvenbode N, Didden R.  2019.  Substance use disorders. Handbook of intellectual disabilities – Integrating theory, research, and practice.

van Duijvenbode N, VanDerNagel JEL.  2019.  A Systematic Review of Substance Use (Disorder) in Individuals with Mild to Borderline Intellectual Disability. Eur Addict Res. :1-20.

Wits E, Croes E, Dijkstra BAG, van Nattum M.  2017.  Standaarden bieden houvast aan alle zorgverleners. Medisch Contact.

Swerts C, Vandevelde S, VanDerNagel JEl, Vanderplasschen W, Claes C, De Maeyer J.  2017.  Substance use among individuals with intellectual disabilities living independently in Flanders.. Res Dev Disabil. 63:107-117.

VanDerNagel JEl, Kiewik M, van Dijk M, Didden R, Korzilius HPLM, van der Palen J, Buitelaar JK, Uges DRA, Koster RA, DeJong CA.  2017.  Substance use in individuals with mild to borderline intellectual disability: A comparison between self-report, collateral-report and biomarker analysis.. Res Dev Disabil. 63:151-159.

VanDerNagel JEL, Kiewik M, Didden R, Korzilius HPLM, van Dijk M, van der Palen J, Buitelaar JK, de Jong CAJ.  2017.  Substance use in individuls with mild to borderline intellectual disability: An exploration of Risks and Rates in the Netherlands. Advances in Neurodevelopmental Disorders. 1(4):283-293.

Kiewik M, VanDerNagel JEl, Kemna L.E.M., Engels RCME, DeJong CA.  2016.  Substance use prevention program for adolescents with intellectual disabilities on special education schools: A cluster randomised control trial. Journal of Intellectual Disability Research. 60(3):191–200.

Kiewik M, VanDerNagel JEl, Kemna LEM, Engels RCME, DeJong CA.  2016.  Substance use prevention program for adolescents with intellectual disabilities on special education schools: a cluster randomised control trial.. J Intellect Disabil Res. 60(3):191-200.

Joosten EAG, Jaspers J, Dijkstra BAG, DeJong CA.  2015.  Samen beslissen in de ggz en verslavingszorg. Nederlands tijdschrift voor evidence based practice. 3:18-20.

Kok T, de Haan HA, Wieske E, van Oene GH de Weert, DeJong CA.  2015.  Screening For Personality Disorders in Outpatient Substance Use Disorder Patients. European Journal of Psychological Assessment.

Kok T, de Haan HA, van der Meer M, Najavits LM, DeJong CA.  2015.  Screening of current post-traumatic stress disorder in patients with substance use disorder using the Depression, Anxiety and Stress Scale (DASS-21): a reliable and convenient measure.. Eur Addict Res. 21(2):71-7.

Kalaitzaki AE, Birtchnell J, Hammond S, DeJong CA.  2015.  The Shortened Person's Relating to Others Questionnaire (PROQ3): Comparison of the Internet-administered Format With The Standard-written One Across Four National Samples.. Psychol Assess.

Magnée EHB, van Oene GH de Weert, Wijdeveld TAGM, Coenen AML, DeJong CA.  2015.  Sleep disturbances are associated with reduced health-related quality of life in patients with substance use disorders.. Am J Addict. 24(6):515-22.

van Duijvenbode N, VanDerNagel JEl, Didden R, Engels RCME, Buitelaar JK, Kiewik M, DeJong CA.  2015.  Substance use disorders in individuals with mild to borderline intellectual disability: Current status and future directions.. Res Dev Disabil. 38C:319-328.

Kok T, de Haan HA, van der Meer M, Najavits LM, DeJong CA.  2014.  Screening of current PTSD in substance use disorder patients with the Depression, Anxiety and Stress Scale (DASS-21): a reliable and convenient measure. European Addiction Research.

Batalla A, Garcia-Rizo C, Castellví P, Fernandez-Egea E, Yücel M, Parellada E, Kirkpatrick B, Martin-Santos R, Bernardo M.  2013.  Screening for substance use disorders in first-episode psychosis: implications for readmission.. Schizophr Res. 146(1-3):125-31.

Bruijnen CJWH, Wester AJ, Markus W, DeJong CA, Kessels RP.  2013.  Screening of cognitive disorders in substance abuse patients using the Montreal Cognitive Assessment - Dutch Version (MoCA-D). Journal of the International Neuropsychological Society. 19(Suppl 2)

Iskandar S, van Crevel RR, Hidayat T, Siregar IMP, Achmad TH, van der Ven AJAM, DeJong CA.  2013.  Severity of psychiatric and physical problems is associated with lower quality of life in methadone patients in Indonesia.. Am J Addict. 22(5):425-31.

Batalla A, Bhattacharyya S, Yücel M, Fusar-Poli P, Crippa JA, Nogué S, Torrens M, Pujol J, Farré M, Martin-Santos R.  2013.  Structural and functional imaging studies in chronic cannabis users: a systematic review of adolescent and adult findings.. PLoS One. 8(2):e55821.

VanDerNagel JEl, Kemna LEM, Didden R.  2013.  Substance use among persons with Mild Intellectual Disability: approaches to screening and interviewing. NADD bulletin. 16(5)

Carpentier PJ, Arias Vasquez A, Hoogman M, Onnink M, Kan CC, Kooij JJS, Makkinje R, Iskandar S, Kiemeney LA, DeJong CA et al..  2012.  Shared and unique genetic contributions to attention deficit/hyperactivity disorder and substance use disorders: A pilot study of six candidate genes.. Eur Neuropsychopharmacol.

Iskandar S, DeJong CA, Hidayat T, Siregar IMP, Achmad TH, van Crevel RR, van der Ven AJAM.  2012.  Successful testing and treating of HIV/AIDS in Indonesia depends on the addiction treatment modality.. J Multidiscip Healthc. 5:329-36.